Selected article for: "acute respiratory syndrome and liver inflammation"
Author: Martinez, Miguel Angel; Franco, Sandra
Title: Impact of COVID-19 in Liver Disease Progression.
  • Cord-id: 2m8smod2
  • Document date: 2021_5_31
    • ID: 2m8smod2
    Snippet: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel coronavirus that causes coronavirus disease 19 (COVID-19), which has infected millions of people worldwide in only a few months. A minority, but significant number, of infected individuals require hospitalization and intensive care. From the start of this new virus pandemic, it was apparent that obese and/or diabetic individuals had a bad prognosis for COVID-19 progression, strongly suggesting an association between liver di
    Document: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel coronavirus that causes coronavirus disease 19 (COVID-19), which has infected millions of people worldwide in only a few months. A minority, but significant number, of infected individuals require hospitalization and intensive care. From the start of this new virus pandemic, it was apparent that obese and/or diabetic individuals had a bad prognosis for COVID-19 progression, strongly suggesting an association between liver disease and severe COVID-19. Because chronic liver disease (CLD) is associated with immune dysregulation and inflammation, it is unsurprising that patients with CLD may carry a greater risk of adverse outcomes following SARS-CoV-2 infection. Initial COVID-19 data have also indicated that healthy infected individuals display abnormal liver function tests, suggesting a possible direct implication of SARS-CoV-2 in liver damage. Here we show that COVID-19 affects the liver metabolism and increases the morbidity and mortality of individuals with underlying CLD.

    Search related documents:
    Co phrase search for related documents
    • abnormal liver and liver cell: 1, 2, 3, 4, 5, 6, 7
    • abnormal liver and liver damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • abnormal liver and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • abnormal liver biochemistry and liver biochemistry: 1, 2, 3, 4, 5, 6, 7
    • abnormal liver biochemistry and liver cell: 1
    • abnormal liver biochemistry and liver disease: 1, 2, 3, 4, 5
    • abnormal liver biochemistry pattern and liver biochemistry: 1
    • abnormal liver biochemistry pattern and liver cell: 1
    • abnormal liver biochemistry pattern and liver disease: 1
    • abnormal liver function and liver biochemistry: 1
    • abnormal liver function and liver cell: 1, 2, 3, 4
    • abnormal liver function and liver damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • abnormal liver function and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • ace inhibitor and activity expression: 1, 2, 3, 4
    • activity expression and liver cell: 1, 2, 3, 4, 5
    • activity expression and liver damage: 1, 2
    • activity expression and liver disease: 1, 2, 3, 4, 5
    • additional study and liver cell: 1
    • additional study and liver disease: 1